Objectives: Many efforts are spent in identifying stem cells in adult pancreas because these could provide a source of A cells for cell-based therapy of type 1 diabetes. Prominin-1, particularly its specific glycosylation-dependent AC133 epitope, is expressed on stem/progenitor cells of various human tissues and can be used to isolate them. We, therefore, examined its expression in adult human pancreas.
R
egulation of the pancreatic A-cell mass represents a critical issue in diabetes research. 1 Diabetes results from loss and/or dysfunction of islet A cells in the pancreas. The disease can be treated by islet cell transplantation, but this therapy is seriously hampered by the shortage of donor organs. Therefore, an important goal of diabetes research is to find additional sources of islet cells. Adult tissue stem cells could provide such a source but it remains a contentious issue whether stem cells reside in adult human pancreas. Stem cells are defined as clonogenic, self-renewing cells that can (re-)generate multiple types of differentiated progeny. It has been reported that cells that are clonogenic and self-renewing and have some degree of multipotency in differentiation can be isolated from rodent pancreas. 2Y4 As for adult human pancreas tissue, it has been suggested that new insulin-producing islet cells can be generated in vitro from exocrine duct cells, 5, 6 but it is not clear whether these cells represented stem cells. An alternative to stem cells as islet precursors is represented by dedifferentiated acinar or ductal exocrine cells that can transdifferentiate into A cells. The transdifferentiation capacity of acinar cells 7Y9 makes it more difficult to interpret studies reporting neogenesis of islet cells from uncharacterized precursor cells. 10 It is generally considered that, in vivo, adult pancreatic stem cells reside in the exocrine ducts. However, a subset of duct cells that could represent stem cells has not yet been identified. In vitro, human pancreatic cytokeratin 19 (CK19)Yexpressing cells were reported to differentiate into islet cells. 6 Cytokeratin 19 is an intermediate filament protein that represents a good marker of human pancreatic duct cells 11 and that is also expressed by immature A cells in the fetal human pancreas. 12 However, duct-type cytokeratins are expressed by all cells lining the exocrine ducts and can also be expressed by dedifferentiated acinar cells. 9, 13 Another candidate marker for pancreatic stem cells that may reside in rodent islets is the intermediate filament protein nestin. 14, 15 However, nestin expression is also found in mesenchymal stellate cells and endothelial cells in the islets, 16 and because of this, it cannot be considered a prospective marker of pancreatic stem cells. The receptor for hepatocyte growth factor, c-met, was proposed as a marker for mouse pancreatic stem cells. 4 This receptor is also expressed by duct epithelial cells in the human pancreas. 17, 18 It must be concluded that the extensive search for a pancreatic stem cell has not yet revealed a way to identify stem cells that may reside in adult pancreas tissue (reviewed by Bonner-Weir and Sharma, 19 Zhang and Sarvetnick, 20 Holland et al, 21 and Street et al 22 24 Its precise physiological function is still unclear (for review, see Fargeas et al 25 and Jászai et al 26 ). Human prominin-1 transcripts are found in various adult tissues, including the pancreas. 27, 28 Prominin-1 protein is expressed in various differentiated cell types, including epithelial cells lining the kidney tubules, mammary gland lactiferous ducts, and epididymal duct. 28, 29 It is also expressed in photoreceptor cells. 26 Several distinct glycoforms of prominin-1 have been described, 29 and a particular prominin-1 epitope recognized by the monoclonal antibody (mAb) AC133 appears structurally dependent on glysosylation. 27 Remarkably, this AC133 epitope has been detected exclusively in human somatic stem and progenitor cells, embryonic epithelia, and putative cancer stem cells so far, 30Y32 leading to the wide use of mAb AC133 for the prospective identification and purification of prominin-1Ypositive stem and progenitor cells from distinct sources that include neural 33 and hematopoietic/endothelial 34, 35 systems, prostate, 36 and kidney. 37 We here report that the ductal cells of the human pancreas express prominin-1 and, surprisingly, its AC133 epitope.
MATERIALS AND METHODS

Sample Preparation and Cell Culture
Human pancreatic tissue samples were obtained from donor organs that were procured by transplant departments affiliated to Eurotransplant Foundation (Leiden, the Netherlands). 38 After collagenase digestion of the pancreas and Ficoll gradient centrifugation of the digest, the exocrine fraction consisting of 35% ductal cells and 55% acinar cells is recovered. 39 Cells were cultured in suspension for 4 to 7 days in RPMI-1640 medium (Invitrogen, Carlsbad, Calif) supplemented with 5% fetal bovine serum (Perbio, Erembodegem, Belgium) under 5% CO 2 atmosphere. The Ethical Committee of the Vrije Universiteit Brussel has approved the experiments.
Immunohistochemistry
For staining of the AC133 epitope (and combined stainings), pancreas samples were frozen in liquid nitrogen. Five-micrometer cryosections were fixed for 10 minutes in buffered 4% formaldehyde. For other stainings, tissue samples and cells were fixed in 4% buffered formaldehyde and embedded in paraffin. The indirect immunostaining method with fluorochrome-conjugated secondary antibodies was used.
The following primary antibodies were used: mouse mAbs CD133/1 (clone AC133) and CD133/2 (clone 293C3) (Miltenyi Biotec, Bergisch Gladbach, Germany) directed against the AC133 and AC141 epitopes of human prominin-1, respectively; rabbit >hE2 antiserum generated against human prominin-1 polypeptide 28 ; rabbit polyclonal anticarbonic anhydrase II (CA-II) and sheep polyclonal anti-CK19 (The Binding Site, Birmingham, UK). FITC-and TRITC-labeled anti-mouse, anti-sheep, and anti-rabbit antibodies (Jackson Immunoresearch, West Grove, Pa) were used as secondary antibodies.
All analyses were performed at least 3 times on different tissue samples.
Electron Microscopy
Cultured exocrine cells were fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4), postfixed in 1% osmium tetroxide, stained with 2% uranyl acetate, dehydrated in a graded ethanol series, and embedded in Epon. Ultrathin sections were examined with a Philips Tecnai 10 electron microscope.
Real-time Polymerase Chain Reaction
Real-time polymerase chain reaction (RT-PCR) was performed to quantify the expression level of prominin-1 transcripts. Total RNA was isolated from cultured exocrine cells using the GenElute Mammalian Total RNA Miniprep kit (Sigma, St Louis, Mo). Complementary DNA was prepared from 500 ng of total RNA after DNase treatment and 10 ng of RNA equivalent used for PCR with specific primers (see below) in the presence of SYBR Green I. Polymerase chain reaction reagents were from Abgene (Epsom, UK). A melt curve analysis was performed at the end of each reaction. Values (mean T SEM) are from 4 independent experiments. Expression levels were normalized to individual glyceraldehyde-3-phosphate dehydrogenase (GAPDH, internal control). Primers were designed to anneal to specific sequences of human prominin-1, 5 ¶-GACCCATTGGCATTCTCTTT-3 ¶ (forward) and 3 ¶-CCCAGGACACAGCATAGAATAA-5 ¶ (reverse), and GAPDH, 5 ¶-ACAGTCAGCCGCATCTTCTTT-3 ¶ (forward) and 3 ¶-CGCCCAATACGACCAAAT-5 ¶ (reverse). Statistical analysis was performed by analysis of variance.
RESULTS
Expression of Prominin-1 in Normal Pancreas Tissue
Normal pancreas tissue was subjected to an immunohistochemical analysis for the expression of prominin-1 using 2 distinct antibodies: the >hE2 antiserum, which recognizes the human prominin-1 polypeptide independently of its glycosylation profile, 28 and the mAb CD133/1 (AC133 clone; hereafter called mAb AC133), which reacts with the glycosylation-dependent AC133 epitope 27 that has been so far specific for undifferentiated cells. Interestingly, both antibodies revealed a prominin-1 immunoreactivity on the apical but not the basolateral side of all epithelial cells lining pancreatic ducts (Figs. 1C, F, see arrows) . Both the small intercalated and the large ducts were labeled. (Another mAb directed against human prominin-1, CD133/2 [293C3 clone], gave the same results [data not shown], whereas no signal was detected when the antiYprominin-1 primary antibody was omitted [data not shown].) Double immunostaining for the duct cell markers CK19 (Fig. 1B) or CA-II (Fig. 1E) confirmed the duct cell nature of the prominin-1Yexpressing cells 
Expression of Prominin-1 in Primary Duct Cells
The nonendocrine cell fraction obtained after islet isolation from pancreas tissue was cultured for up to 7 days in suspension. We followed the expression of prominin-1 in this fraction during the culture period to investigate whether the increase in amount of ductal cells is concordant with an increase in prominin-1 expression.
Prominin-1 staining was seen in a fraction of the cells that coexpressed duct cell markers, as was shown with the mAb AC133 (Fig. 2, arrows) , and that increased in number with time of culture. This relative increase in prominin1Yexpressing cells (as is shown in Fig. 3 with the >hE2 antiserum) most likely resulted from the better survival of duct cells compared to the acinar cells, and possibly from transdifferentiation of some acinar cells into ductlike cells. At day 7 of culture, prominin-1 immunoreactivity was expressed mainly at the outer surface of the aggregates (Fig. 3C,  arrows) . In agreement with the exclusive subcellular localization of prominin-1 in microvilli, 24, 40 transmission electron microscopy revealed that the epithelial cells at the outer surface of the aggregates contained numerous microvilli (Fig. 4) .
Finally, expression of prominin-1 in the exocrine pancreas fraction was confirmed by RT-PCR analysis, showing an increase of more than 2-fold in the relative prominin-1 messenger RNA (mRNA) level after 1 week of culture ( Fig. 5 ; P G 0.05).
DISCUSSION
Several studies had reported the expression of prominin-1 mRNA in normal adult human pancreas 27, 28, 41 and in ductal cells from pancreatic juice of patients with pancreatic ductal carcinoma, 42 but evidence of the localization of the protein in the human pancreas was lacking. We here report that prominin-1 protein is actually present in ductal epithelial cells all along the pancreatic ducts. As expected, the protein was located exclusively at the apical membrane of the epithelial cells, facing the lumen. Most notably, and in contrast to other adult epithelia such as kidney, 28 the cells that react with the >hE2 antiserum also displayed the AC133 epitope, which had been reported to be restricted so far to stem and progenitor cells and to developing epithelia in normal individuals 27, 28, 32, 34 and was, therefore, considered a stem cellYspecific marker. It appears here that the AC133-positive pancreatic duct cells are fully specialized cells as they do express CA-II and cannot represent an undifferentiated stem cell population. Interestingly, it has been hypothesized that mature duct cells can transiently regain a less differentiated phenotype and, thereby, serve as a multipotent progenitor in conditions of tissue injury and regeneration. This type of progenitor was named functional or facultative stem cells. 19, 43 In fact, this type of regeneration represents transdifferentiation (ie, a conversion of one differentiated cell type into another). 9, 44 Both ductal cells and acinar exocrine cells in rodents can dedifferentiate and reexpress embryonic characteristics like the transcription factor Pdx1. 13, 43 Acinar cells can transdifferentiate to insulin-producing A cells 8 or to hepatocyte-like cells. 45 Transdifferentiation, however, is clearly distinct from the derivation of cells from true and undifferentiated stem cells. The relative increase with time of prominin-1 mRNA expression in primary cell culture of nonendocrine pancreas cells can be explained by an enrichment of cells with ductal phenotype in these cultures. After a few days of culture, acinar cells die, whereas duct cells selectively survive and, hence, reach a frequency greater than 90%. 39, 46 In multicellular aggregates with ductal phenotype, prominin-1 was most strongly expressed at the outer surface of these aggregates.
In a previous study, Miraglia et al 27 failed to detect immunoreactivity for AC133 in paraffin sections from pancreas, despite a strong prominin mRNA level. The apparent discrepancy with our study is likely to be caused by differences in tissue processing; indeed, we could not obtain reproducible immunostaining with this antibody on paraffin sections, although it worked very well on cryosections. However, in agreement with our results, 2 recently published studies show flow cytometric sorting of ductal cells from the mouse fetal, neonatal, and adult pancreas using CD133 antibody. 47, 48 It has been estimated that between 0.02% and 0.03% of murine pancreatic islet and duct cells are clonogenic and could represent stem and progenitor cells. 3, 4 In the human pancreas, approximately 30% of the cells are ductal cells 11 and express prominin-1. We conclude that the AC133 epitope is not an exclusive stem and progenitor cell marker but that it may also be expressed by certain differentiated cells, such as the pancreatic duct cells. Hence, in the pancreas, prominin-1 cannot be used as a simple stem cell marker.
